Half-life and dosing frequency are the primary differences
The goal is to raise blood pressure only enough to ensure sufficient blood flow to the brain while minimizing risks
Think of a peptide as a text message your cells send each other with a single instruction: "make more collagen here," "reduce inflammation there," "build new blood supply now." BPC-157's message is remarkably good at all three
Snchez-Fernndez C, Entrena JM, Baeyens JM, Cobos EJ
However, it didnt cure schizophrenia.[ref] For COPD, a meta-analysis showed that lower doses (1200mg/day or less) for a duration of three months seemed to work best.[ref] A study in MS patients showed that 600 mg/2x/day did not significantly increase serum glutathione levels
Both are powerful tools, but working with a peptide expert ensures you're choosing whats best for your body